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Abstract We demonstrated previously that shortened forms of
(stem II-deleted) hammerhead ribozymes with low intrinsic
activity form very active dimers with a common stem II (very
active short ribozymes capable of forming dimers were
designated maxizymes). As a result of such a dimeric structure,
heterodimeric maxizymes are potentially capable of cleaving a
substrate at two different sites simultaneously. In this case, active
heterodimers are in equilibrium with inactive homodimers.
Longer forms of common stem II can lead to enrichment of the
active heterodimers in vitro. In this study, we investigated
whether the cationic detergent CTAB, which is known to enhance
strand displacement of nucleic acids, might inhibit the dimeriza-
tion of maxizymes. Significantly, under all conditions examined,
CTAB instead enhanced the activity of a variety of maxizymes,
with the extent of enhancement depending on the conditions. The
activity of our least stable, least active maxizyme was enhanced
100-fold by CTAB. The strand displacement activity of CTAB
thus appears to enhance the conversion of alternative conforma-
tions of inactive maxizymes, with intra- and inter-molecular
hydrogen bonds, to active forms. Thus, our smallest maxizyme
can also be considered a potential candidate for a gene-
inactivating agent in vivo, in view of the fact that various
facilitators of strand displacement reactions are known to exist
in vivo (indeed, a separate experiment in cell culture supported
the conclusion that our smallest maxizyme is a good gene-
inactivating agent). Although activities of ribozymes in vitro do
not necessarily reflect their activities in vivo, our findings suggest
that the activity of ribozymes in vivo can be better estimated by
running ribozyme kinetics in the presence of CTAB in vitro.
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1. Introduction
The hammerhead ribozyme is one of the smallest RNA
enzymes [1^4] (Fig. 1A). Because of its small size and poten-
tial utility as an antiviral agent it has been investigated exten-
sively in terms of the mechanism of its action and possible
applications in vivo [1^8]. The hammerhead ribozyme was
¢rst recognized as the sequence motif responsible for the
self-cleavage (cis action) of the satellite RNAs of certain vi-
ruses [9^11]. The putative consensus sequence required for
activity has three duplex stems and a conserved ‘core’ of
two non-helical segments, plus an unpaired nucleotide at the
cleavage site. The trans-acting hammerhead ribozyme [3] con-
sists of an antisense section (stem I and stem III) and a cata-
lytic domain with a £anking stem/loop II section. Such RNA
motifs can cleave RNA targets at speci¢c sites (most e¡ec-
tively at GUC [12^17]).
In attempts to identify functional groups and to elucidate
the role of the stem II region, various modi¢cations and dele-
tions have been made in this region [4,18^24]. For the appli-
cation of such enzymes as therapeutic agents for the treatment
of infectious diseases, minimized hammerhead ribozymes
(minizymes) seem to be particularly attractive because such
removal would obviously reduce the cost of synthesis, and
increase the overall yield of the desired polymer and simplify
puri¢cation. However, the activities of minizymes are two to
three orders of magnitude lower than those of the parental
hammerhead ribozymes, an observation that led to the sug-
gestion that minizymes might not be suitable as gene-inacti-
vating reagents [23]. Thus, conventional hammerhead ribo-
zymes with a deleted stem II (minizymes) came to be
considered crippled structures, attracting minimal interest be-
cause of their extremely low activity, as compared to that of
the full-sized ribozyme. However, we recently identi¢ed very
active short ribozymes and we presented evidence that short
ribozymes with such high-level activity actually form dimeric
structures [4,25] (Fig. 1B). In order to distinguish monomeric
forms of conventional minizymes that have extremely low
activity from our novel dimers with high-level activity, the
latter very active short ribozymes capable of forming dimers
are designated ‘maxizymes’. We also demonstrated that heter-
odimeric maxizymes might be potentially useful as gene-inac-
tivating agents since a heterodimer, because of its two inde-
pendent catalytic cores (Figs. 1C and 2), can cleave a single
substrate at two independent sites simultaneously (in contrast
to homodimeric maxizymes that cleave at one site only Fig.
1B). In previous reports we described the physical properties
of various kinds of homodimeric and heterodimeric maxi-
zymes, and we demonstrated that all heterodimeric maxizymes
tested were capable of cleaving the HIV-1 tat mRNA [4,25,26]
at two GUC triplets simultaneously (Fig. 2). Simultaneous
cleavage resulted in an overall increase in the e⁄ciency of
degradation of the target RNA [25,26]. Moreover, we found
that the activity of the maxizymes in vitro increased with
increases in the length of the common stem II of the dimer
[25]. The stability of the dimeric structure depends not only on
the number of G-C pairs in the common stem II of the di-
meric maxizyme but also on the concentration of Mg2 ions
and on whether or not substrate molecules are bound to the
dimer [4,25].
Many so-called facilitators have recently been identi¢ed
that signi¢cantly increase the rates of formation of RNA du-
plexes and of ribozyme-catalyzed reactions [27^38]. These fa-
cilitators include nuclear proteins, the HIV-1 nucleocapsid
(NC) protein, and cationic detergents. It seems possible, there-
fore, that the capacity of ribozymes for the rapid and speci¢c
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cleavage of RNAs in vivo might be enhanced by such facili-
tators if ribozymes or substrates in an inactive conformation
could be converted to active forms in vivo.
The dimerization of maxizymes is a complicated process. In
this case, there is a possibility that the strand displacement
activity of CTAB might inhibit the dimerization process of
maxizymes. Therefore, in this study, we investigated the e¡ect
(stimulatory or inhibitory) of just one cationic detergent,
namely CTAB (cetyltrimethylammonium bromide), on the
overall activity of maxizymes; one with a long common
stem II that can form a stabler and active heterodimer, and
the other one with a short common stem II that yields sig-
ni¢cantly higher proportions of inactive homodimers in vitro
(Figs. 1 and 3). We demonstrate that the strand displacement
activity of CTAB appears to enhance the conversion of alter-
native conformations of inactive maxizymes, with intra- and
inter-molecular hydrogen bonds, to active forms so that the
maxizyme with a short common stem II gains signi¢cantly
higher activity in vitro in the presence of CTAB. This ¢nding
is in agreement with the conclusion based on a separate ex-
periment that the maxizyme with a short common stem II is
as active as the maxizyme with a long common stem II in
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Fig. 1. Secondary structures of (A) the wild-type hammerhead ribozyme (R32), (B) the maxizyme that is capable of forming a homodimer, and
(C) the heterodimeric maxizyme. A schematic representation of the overall folding of the hammerhead ribozyme is shown in A on the right.
Homodimeric maxizymes have two identical substrate-binding sites, whereas the MzL-MzR heterodimeric maxizyme can generate two di¡erent
binding sites: one is complementary to the sequence of the substrate (S11), that we used in this study and the other is complementary to a sub-
strate with a di¡erent sequence (in this ¢gure, an uncleavable pseudosubstrate is shown). S11 can be cleaved only after the formation of a di-
meric maxizyme.
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cultured cells, wherein various facilitators exist that enhance
strand displacement reactions similarly to CTAB. This in turn
suggests that CTAB might be useful in predicting activities of
ribozymes in vivo.
2. Materials and methods
2.1. Synthesis of maxizymes and substrates
Maxizymes and their short substrates Figs. 1 and 3 were synthe-
sized chemically by a DNA/RNA synthesizer (model 394; Perkin El-
mer, Applied Biosystems (ABI), Foster City, CA, USA). Reagents for
RNA synthesis were purchased from Glen Research (Sterling, VA,
USA). Oligonucleotides were puri¢ed as described in the user bulletin
from ABI (53, 1989) with minor modi¢cations. Further puri¢cation
was performed by polyacrylamide gel electrophoresis, as described
previously [4,25].
2.2. Measurements of kinetic parameters
Measurements of kinetic parameters of reactions catalyzed by max-
izymes were made with 5P-32P-labeled short substrates: S19 (5P-CA-
GAACAGUCAGACUCAUC-3P), which included GUC triplet-2 of
272-meric HIV-1 tat mRNA, was used for the reactions mediated
by 2 bp and 5 bp dimeric maxizymes (Fig. 3A,B), and S11 (5P-
GCCGUCCCCCG-3P) was used for the reactions mediated by homo-
dimeric and heterodimeric maxizymes (Fig. 1B,C). The terms 2 bp and
5 bp dimeric maxizymes refer to dimeric maxizymes with two and ¢ve
G-C pairs, respectively, in the common stem II. Reaction rates were
measured, in 25 mM MgCl2, 50 mM Tris-HCl (pH 8.0) and 10 mM
NaCl under single-turnover conditions at 37‡C, in the presence or
absence of 50 WM CTAB (Sigma, St. Louis, MO, USA).
Reactions were initiated by the addition of appropriate amounts of
MgCl2 after pre-incubation of reaction mixture that contained all
components apart from MgCl2 for several minutes at 37‡C. Reactions
were stopped by the removal of aliquots from the reaction mixture at
appropriate intervals and mixing them with an equivalent volume of a
solution that contained 100 mM EDTA, 9 M urea, 0.1% xylene cya-
nol, and 0.1% bromophenol blue. The substrate and the products of
the reaction were separated by electrophoresis on a 5%^20% poly-
acrylamide/7 M urea denaturing gel and were detected by autoradiog-
raphy. The extent of cleavage was determined by quantitation of
radioactivity in the bands of substrate and products with a Bio-Image
Analyzer (BAS2000; Fuji Film, Tokyo).
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Fig. 2. Simultaneous cleavage of HIV-1 tat mRNA at two sites by a dimeric maxizyme. A: The secondary structure of HIV-1 tat mRNA, as
predicted by MulFold (Biocomputing O⁄ce, Biology Department, Indiana Univ., IN, USA). Cleavage site 1 (GUC triplet-1) and cleavage site
2 (GUC triplet-2) are indicated by arrows. B: Simultaneous cleavage (scissors) of a target mRNA at two sites by a dimeric maxizyme.
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2.3. Measurement of the melting temperature (Tm) of each dimeric
maxizyme
In order to determine the Tm of each maxizyme (2 bp maxizyme left
(2 bp MzL), 2 bp maxizyme right (2 bp MzR), 5 bp maxizyme left (5
bp MzL) and 5 bp maxizyme right (5 bp MzR); Fig. 3), we monitored
the thermal denaturation of ribozymes with a UV spectrophotometer
(model 2100S; Shimadzu, Kyoto). Solutions of maxizymes (2 WM)
were prepared in 50 mM Tris-HCl bu¡er (pH 8.0). After degassing,
these samples, without Mg2 ions, were heated at 80‡C for 3 min and
then slowly cooled to 5‡C over the course of 20 min. Then a concen-
trated solution of Mg2 ions was added to each sample to give a ¢nal
concentration of MgCl2 of 25 mM. The absorption of the samples at
260 nm was monitored continuously at 5‡C for 10 min and then the
temperature was raised from 5‡C to 80‡C at a rate of 1‡C/min. The
Tm was determined by plotting the derivative of the thermal denatu-
ration curve.
3. Results and discussion
3.1. Kinetic analysis of the reaction catalyzed by a 5 bp dimeric
maxizyme targeted to HIV-1 mRNA
Our previous analysis indicated that increases in the length
of the common stem II are associated with increases in the
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Fig. 3. Secondary structures of dimeric maxizymes that target HIV-
1 tat mRNA. A: The 2 bp dimeric maxizyme with two G-C pairs
in the common stem II. B: The 5 bp dimeric maxizyme with ¢ve G-
C pairs in the common stem II. The short substrate of 19 nucleoti-
des (S19), indicated by a long bracket, was used in this study.
6
Fig. 4. Reaction scheme of the cleavage mediated by dimeric maxizymes and hammerhead ribozymes. The upper panel shows the reaction
scheme for dimeric maxizymes and the lower panel shows that for the parental hammerhead ribozyme. The dimeric maxizymes are more likely
to exist in their inactive conformations than in their active conformations.
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activity of dimeric maxizymes in vitro [25]. Maxizymes with
larger numbers of base pairs in the common stem II probably
form a larger proportion of active dimers [25]. Our smallest
maxizymes can form two G-C pairs in the common stem II
and the dimeric maxizyme with the longest common stem II
has ¢ve G-C pairs in this region. Since the 5 bp maxizyme has
the highest activity [25] and since CTAB has been shown to
enhance the activity of wild-type ribozymes by enhancing
strand displacement [34^38], we ¢rst investigated the e¡ect
of CTAB on the 5 bp dimeric maxizyme targeted to GUC
triplet-1 and GUC triplet-2 in HIV-1 tat mRNA (272 mer;
Figs. 2 and 3B). Our preliminary results indicated that CTAB
had a stimulatory rather than an inhibitory e¡ect (without
inhibition of dimerization) when the relatively long 272-meric
HIV-1 tat mRNA was used as the substrate (Fig. 2A). In
order to quantitate the stimulation by CTAB, we then used
a short substrate of 19 nucleotides, S19, that corresponded to
part of the HIV-1 tat mRNA. This substrate is cleaved into a
10-meric 5P-side product (labeled P in Fig. 4) and a 9-meric 3P-
side product by the dimeric maxizyme.
We performed a kinetic study of reaction mixtures that
contained 50 mM Tris-HCl (pH 8.0), 10 mM NaCl, and 25
mM MgCl2, at 37‡C under single-turnover conditions, using a
¢xed concentration of the 5 bp maxizyme that was close to its
apparent Km of 0.22 WM [25] and a ¢xed concentration of
CTAB (50 WM) that was slightly above its critical micelle
concentration (CMC). As shown in Fig. 5, CTAB not only
increased the yield of products (Fig. 5A) but it also enhanced
the initial rate (Fig. 5B). We recorded values of kobs = 0.13
min31 and kobs = 0.55 min31, respectively, in the absence
and in the presence of CTAB. These results suggested that
CTAB enhanced the association step (kassoc in Fig. 4) of the
reaction since we followed the reactions under so-called kcat/
Km conditions and since CTAB is known to inhibit the chem-
ical cleavage step (kcleav) [35,37]. We obtained analogous re-
sults with the long HIV-1 tat mRNA substrate (272-mer; data
not shown).
3.2. Kinetic analysis of the reaction catalyzed by a 2 bp dimeric
maxizyme targeted to GUC triplet-2 of HIV-1 mRNA
Since CTAB had a stimulatory e¡ect on the reaction cata-
lyzed by the 5 bp maxizyme, we next examined its e¡ect on
the 2 bp dimeric maxizyme, which had two G-C pairs in the
common stem II (Fig. 3A). Since the 2 bp maxizyme was
expected to be less stable than the 5 bp maxizyme, we feared
initially that CTAB might have an inhibitory e¡ect on the
activity of the 2 bp maxizyme because of its strand displace-
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Fig. 5. E¡ects of CTAB on cleavage catalyzed by the 5 bp dimeric
maxizyme. A: Time courses of cleavage reactions catalyzed by the
5 bp dimeric maxizyme in the presence (open circles) and in the ab-
sence (closed circles) of CTAB. B: The initial rates of the reactions
catalyzed by the 5 bp dimeric maxizyme in the presence and in the
absence of CTAB. Pt is the relative amount of product at any time
[45].
Fig. 6. E¡ects of CTAB on cleavage catalyzed by the 2 bp dimeric
maxizyme. A: Autoradiogram showing the cleavage of the short
substrate S19 by the 2 bp dimeric maxizyme in the presence (left)
and in the absence (right) of 50 WM CTAB. B: Time courses of
cleavage reactions catalyzed by the 2 bp dimeric maxizyme in the
presence and in the absence of CTAB. C: The initial rates of the re-
actions catalyzed by the 2 bp dimeric maxizyme in the presence and
in the absence of CTAB. Cont., control (labeled substrate only);
Sub., substrate; Pro., product. For de¢nition of Pt, see legend to
Fig. 5.
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ment activity [34^38]. Reactions were performed, as men-
tioned above, in 50 mM Tris-HCl (pH 8.0), 10 mM NaCl,
and 25 mM MgCl2 at 37‡C, under single-turnover conditions
and with a ¢xed concentration of the 2 bp maxizyme that was
close to its apparent Km of 1.0 WM [25]. We used a ¢xed
concentration of CTAB (50 WM) and the same 19-mer sub-
strate (S19) as described above. The results of the analysis are
shown in Fig. 6. To our surprise, CTAB had a signi¢cant
stimulatory e¡ect (Fig. 6A). CTAB not only increased the
yield of products (Fig. 6B) but it also enhanced the initial
rate (Fig. 6C) to a signi¢cant extent. We recorded values of
kobs = 0.001 min31 and kobs = 0.1 min31, respectively, in the
absence and in the presence of CTAB. Thus, the rate of the
reaction was increased 100-fold.
In the case of 2 bp heterodimeric maxizymes, the dimers are
expected to generate a mixture of inactive (MzRcMzR) dimers
(consisting of two identical forms of maxizyme right), inactive
(MzLcMzL) dimers (consisting of two identical forms of max-
izyme left), and the desired active (MzRcMzL) dimers (con-
sisting of maxizyme right and maxizyme left). It is partly
because of this mixed population of dimers that the activity
of 2 bp maxizymes is so low, in the absence of CTAB, as
compared with that of 5 bp maxizymes (Fig. 7A,B). In the
case of 5 bp heterodimeric maxizymes, the sequence of the
common stem II was designed such that the equilibrium con-
centration of the active complexes with perfect base pairing in
the common stem II would be much higher than that of in-
active complexes with only partial base pairing (Fig. 7B).
Moreover, the 2 bp maxizymes themselves seem to be folded
in a complicated manner, since the second derivative curves of
their UV absorption spectra have more transitions, each of
which re£ects the melting of intra- or intermolecular base
pairing interactions (Fig. 7C^F). Similar results, indicating
that the 2 bp maxizymes fold in a complicated manner,
were obtained with mixtures of 2 bp heterodimeric maxizymes
[25]. Note that the dimeric structure is stabilized not only by
the formation of two G-C pairs at the common stem II but
also, very probably, by additional interactions that include
two reversed-Hoogsteen G-A base pairs between G8-A13 and
A9-G12, and a non-Watson-Crick A14-U7 base pair that con-
sists of one hydrogen bond, as indicated by dotted lines in
Fig. 1. The extended stem II is stacked on the non-Watson-
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Fig. 7. Stimulation by CTAB of the conversion of inactive dimers to active dimers. A: Active and inactive dimeric forms of 2 bp dimeric maxi-
zymes. A large fraction of the population of dimers is expected to be in an inactive form. B: The active and inactive dimeric forms of the 5 bp
dimeric maxizymes. The formation of active forms is favored because perfect base pairing occurs only in the case of active complexes. C: Sec-
ond derivative curve of the melting curve of the 2 bp maxizyme left (2 bp MzL). D: Second derivative curve for the 2 bp maxizyme right (2
bp MzR). E: Second derivative curve for the 5 bp maxizyme left (5 bp MzL). F: Second derivative curve for the 5 bp maxizyme right (5 bp
MzR).
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Crick base pair, A15:1-U16:1, with resultant formation of a
pseudo-A-form helix by stems II and III [39^43].
CTAB apparently overcame the negative properties of 2 bp
maxizymes. In the presence of CTAB, the activity of the 2 bp
maxizyme approached that of the 5 bp maxizyme. The action
of CTAB resembled that of an RNA chaperon [35], appar-
ently inducing maxizymes that had misfolded (Fig. 7) to refold
into an active conformation.
3.3. Comparison of the activities of homodimeric and
heterodimeric maxizymes targeted to S11
CTAB facilitated the conversion of inactive dimers to active
dimers (Fig. 7A,B). In order to examine whether the CTAB-
mediated activation was due solely to the conversion of mis-
paired dimeric maxizymes to correctly paired dimeric maxi-
zymes, we extended our study to include homodimeric maxi-
zymes [4,43]. The homodimeric maxizyme we chose
(homodimer; Fig. 1B) cleaved the 11-meric substrate (S11).
The corresponding heterodimeric maxizyme (heterodimer;
Fig. 1C) was also able to cleave the same S11 substrate, albeit
at one site only. We did not expect the homodimeric maxi-
zyme to be active in its monomeric con¢guration (Fig. 1B,
left) since all active maxizymes seem able to form favorable
base pairs at the common stem II.
We used the same reaction conditions as described above
with ¢xed concentrations of maxizymes that were close to the
apparent Km values of 5.0 WM (Fig. 8A,B) and 0.5 WM (Fig.
8C,D), respectively [4], for the homodimer and heterodimer.
In the case of the homodimer (Fig. 8A,B), we recorded values
of kobs = 0.20 min31 and kobs = 0.75 min31, respectively, in the
absence and in the presence of CTAB. Even in the case of the
homodimeric maxizyme, CTAB increased the rate up to
3-fold. This ¢nding is in accord with the previous conclusion
[34^38] that CTAB enhances the annealing of a ribozyme to
its substrate. It is also possible that in this case, CTAB in-
duced correct folding of intramolecularly misfolded maxi-
zymes, as demonstrated in the case of 2 bp and 5 bp dimeric
maxizymes (Fig. 7C^F).
With the heterodimeric maxizymes (Fig. 8C,D), the en-
hancement by CTAB was much greater (36-fold) and we re-
corded values of kobs = 0.0045 min31 and kobs = 0.16 min31,
respectively, in the absence and in the presence of CTAB.
Even though the homodimer and the heterodimer had the
same number of G-C pairs in the common stem II and even
though they were directed at the same target, in other words,
they were directed at the same substrate-binding site, it was
apparent that there was di¡erence in the extent of enhance-
ment of their activities by CTAB. The greater enhancement by
CTAB of activities of the heterodimeric maxizyme indicates
that higher concentrations of inactive complexes, such as
MzRcMzR and MzLcMzL (Fig. 4), were present in the ab-
sence of CTAB and were converted to active complexes
(MzRcMzL) by CTAB.
We examined the e¡ects of CTAB not only under kcat/Km
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Fig. 8. E¡ects of CTAB on cleavage catalyzed by the homodimeric maxizyme and the heterodimeric maxizyme. A: Time courses of cleavage re-
actions catalyzed by the homodimeric maxizyme in the presence and in the absence of CTAB. B: The initial rates of reactions catalyzed by the
homodimeric maxizyme in the presence and in the absence of CTAB. C: Time courses of cleavage reactions catalyzed by the heterodimeric
maxizyme in the presence and in the absence of CTAB. D: The initial rates of the reactions catalyzed by the heterodimeric maxizyme in the
presence and in the absence of CTAB. For de¢nition of Pt, see legend to Fig. 5.
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conditions with low concentrations of maxizymes but also
under kcat conditions. Even when concentrations of maxi-
zymes were ¢ve-fold higher than their Km values, we observed
relatively small stimulatory e¡ects in the presence of CTAB,
on the cleavage mediated by both homodimeric and hetero-
dimeric maxizymes (data not shown). In contrast, in a pre-
vious report Herschlag et al. [35] stated that CTAB inhibited
the rate of the chemical cleavage step in a reaction catalyzed
by a native hammerhead ribozyme. However, in the case of
our dimeric maxizymes, even under the above-mentioned con-
ditions signi¢cant concentrations of unfavorable intra- or in-
ter-molecularly bonded structures must have been present, as
they were under kcat/Km conditions. Therefore, it appears that
added CTAB was able to refold inactive conformers to yield
active conformation during the incubation for several minutes
at 37‡C that preceded the addition of an appropriate amounts
of MgCl2.
In summary, we demonstrated that CTAB enhanced the
activity of both homodimeric and heterodimeric maxizymes,
being more e⁄cient in the latter case, under both kcat and kcat/
Km conditions. CTAB appeared to act via enrichment for
active complexes of maxizymes under all conditions examined.
4. Conclusion
It was believed initially that minizymes are signi¢cantly less
active than the corresponding full-sized ribozymes. However,
the activities of our dimeric maxizymes are equal to those of
parental hammerhead ribozymes, despite their smaller size
[4,25]. Moreover, for cleavage of a long substrate, namely,
the tat mRNA transcribed from HIV-1, synthetic maxizymes
are more e¡ective than full-sized ribozymes [25]. The present
study demonstrates that the activities of dimeric maxizymes
can be further stimulated by CTAB. The strand displacement
activity of CTAB appears to enhance the conversion of inac-
tive misfolded maxizymes, to active appropriately folded
forms. In vivo, various facilitators exist that enhance strand
displacement reactions similarly to CTAB, and they are ex-
pected to have stimulatory e¡ects on the activities of dimeric
maxizymes. Even maxizymes with a short stem II such as 2 bp
dimeric maxizymes, which tend to form inactive structures in
vitro, were found to have signi¢cant activity in the presence of
CTAB, suggesting that they might be useful in vivo. In fact, in
a separate experiment, in which we expressed 2 bp dimeric
maxizymes in HeLa cells under the control of the pol III
promoter, the maxizymes exhibited high-level activity that
was at least as high as that of 5 bp dimeric maxizymes [26].
These observations further strengthen the conclusion reached
in the present study that various kinds of facilitator in vivo
that function similarly to CTAB might enhance the activity of
dimeric maxizymes. Thus, dimeric maxizymes [4,25,26,43,44]
should be considered as potentially powerful gene-inactivating
agents in vivo. Moreover, CTAB appears to be useful in pre-
dicting activities of ribozymes in vivo.
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